C12N 2760/20043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2760/20043 (Viral genome or elements thereof as genetic vector) appears on 17 US grants and 33 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 33
- Assignees
- 26
- Inventors
- 53
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 3 |
| 2020 | 2 | 4 |
| 2021 | 2 | 5 |
| 2022 | 0 | 3 |
| 2023 | 3 | 4 |
| 2024 | 1 | 4 |
| 2025 | 3 | 1 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Sequential heterologous boost oncolytic viral immunotherapy25 Aug 2026US 12,714,733 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Recombinant rhabdovirus encoding for CCL2128 Oct 2025US 12,453,749 B2Boehringer Ingelheim International GmbH
- Recombinant oncolytic virus8 Jul 2025US 12,351,812 B2Georgia State University Research Foundation, Inc.
- Multivalent vaccines for rabies virus and coronaviruses8 Apr 2025US 12,269,155 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein24 Dec 2024US 12,171,795 B2Boehringer Ingelheim International GmbH
- Novel vsv virus formulations7 May 2026US 2026/0124288 A1Emergent Product Development Gaithersburg Inc.
- Neddylation-activating enzyme inhibitors as viral sensitizers and uses thereof15 Jan 2026US 2026/0015592 A1Ottawa Hospital Research Institute
- Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein20 Feb 2025US 2025/0057900 A1Boehringer Ingelheim International GmbH
- Chimeric pseudotyped recombinant rabies virus3 Oct 2024US 2024/0327802 A1Beam Therapeutics Inc.
- Recombinant viral expression vectors and methods of use6 Jun 2024US 2024/0182916 A1North Carolina State University
Most cited
By later US patents
- Methods for making modified recombinant vesiculoviruses51US 6,168,943 AYale University · 2001
- Recombinant vesiculoviruses and their uses39US 7,153,510 B1Yale University · 2006
- Apparatus for releasably holding a socket11US 11,091,778 B22021
- Multivalent vaccines for rabies virus and coronaviruses1US 11,041,170 B2The United States of America as represented by the Secretary, Department of Health and Human Service · 2021
- Apparatus for releasably holding a socket1US 11,826,895 B22023